Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples

Author： di Iasio Maria  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.4, 2012-08, pp. : 1761-1765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation

By  

Current Drug Targets, Vol. 19, Iss. 14, 2018-10 ,pp. : 1721-1729

Bentham Science Publishers

Access to resources Recommend Favorite

Serum miR‐146a, miR‐155, and miR‐210 as potential markers of Graves’ disease

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 503-508

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial miRNA (MitomiR): a new player in cardiovascular health

By Srinivasan Hemalatha   Das Samarjit  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 10, 2015-01 ,pp. : 855-861

NRC Research Press

Access to resources Recommend Favorite

miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir

By  

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 142-150

Bentham Science Publishers

Access to resources Recommend Favorite